Trident Texofab Ltd — Updates, 29-05-2025: Company Update

Trident Texofab Limited has announced a board meeting to discuss the financial results for the quarter and half-year. The company raised Rs. 40.86 Cr through preferential issue of warrants, with no deviation in fund utilization. By March-end, Rs. 28.53 Cr had been utilized primarily for working capital and general corporate purposes. The upfront payment received includes Rs. 10.21 Cr for warrants subscription and Rs. 18.31 Cr for conversion of a portion of warrants into equity shares. This capital inflow supports operational funding and growth plans.